LSTA
Price
$2.43
Change
+$0.03 (+1.25%)
Updated
Jun 18 closing price
Capitalization
20.64M
60 days until earnings call
RAIN
Price
$3.05
Change
-$0.20 (-6.15%)
Updated
Jun 18 closing price
Capitalization
38.19M
Interact to see
Advertisement

LSTA vs RAIN

Header iconLSTA vs RAIN Comparison
Open Charts LSTA vs RAINBanner chart's image
Lisata Therapeutics
Price$2.43
Change+$0.03 (+1.25%)
Volume$14.92K
Capitalization20.64M
RAIN ENHANCEMENT TECHNOLOGIES HOLD
Price$3.05
Change-$0.20 (-6.15%)
Volume$16.23K
Capitalization38.19M
LSTA vs RAIN Comparison Chart in %
Loading...
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAIN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LSTA vs. RAIN commentary
Jun 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSTA is a Hold and RAIN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 19, 2025
Stock price -- (LSTA: $2.43)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LSTA’s FA Score shows that 1 FA rating(s) are green while.

  • LSTA’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LSTA’s TA Score shows that 4 TA indicator(s) are bullish while RAIN’s TA Score has 4 bullish TA indicator(s).

  • LSTA’s TA Score: 4 bullish, 3 bearish.
  • RAIN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, LSTA is a better buy in the short-term than RAIN.

Price Growth

LSTA (@Biotechnology) experienced а -1.22% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.32%. For the same industry, the average monthly price growth was +13.75%, and the average quarterly price growth was +8.90%.

Reported Earning Dates

LSTA is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+7.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RAIN($38.2M) has a higher market cap than LSTA($20.6M). RAIN YTD gains are higher at: 152.066 vs. LSTA (-18.456). LSTA has higher annual earnings (EBITDA): -21.48M vs. RAIN (-73.57M). RAIN has more cash in the bank: 77.3M vs. LSTA (25.8M). LSTA has less debt than RAIN: LSTA (92K) vs RAIN (456K). LSTA has higher revenues than RAIN: LSTA (1M) vs RAIN (0).
LSTARAINLSTA / RAIN
Capitalization20.6M38.2M54%
EBITDA-21.48M-73.57M29%
Gain YTD-18.456152.066-12%
P/E RatioN/AN/A-
Revenue1M0-
Total Cash25.8M77.3M33%
Total Debt92K456K20%
FUNDAMENTALS RATINGS
LSTA: Fundamental Ratings
LSTA
OUTLOOK RATING
1..100
55
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LSTARAIN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 28 days ago
78%
Bullish Trend 14 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAIN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CARE16.630.29
+1.77%
Carter Bankshares
HLT247.560.59
+0.24%
Hilton Worldwide Holdings
CBT73.090.06
+0.08%
Cabot Corp
CNNE19.79N/A
N/A
Cannae Holdings
AKTX1.15-0.03
-2.54%
Akari Therapeutics plc